$AUNA

Auna Q2 Earnings Call Highlights

Auna reported Q2 revenue growth in Mexico (4% YoY), Peru (8%), and Colombia (13%), but adjusted EBITDA varied. Mexico's EBITDA declined 16% YoY due to investments, while Peru's was flat due to billing penalties. Colombia's EBITDA fell 12% YoY but rose 18% sequentially. The company reaffirmed its full-year guidance, expecting 12% FX-neutral revenue growth and adjusted EBITDA growth toward the low end of its 10-14% target range, excluding Peru's billing penalties. Cash flow and leverage improved,

Original reporting
Published Aug 20, 2026, 9:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 20, 2026, 9:47 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Auna Q2 Earnings Call Highlights — source image
Decision brief

The 30-second read

$AUNANeutralMed
01

Why it matters

The Q2 results provide fresh data on revenue growth, cost structure, and cash generation, informing short‑term trading decisions.

02

Market read

Earnings release offers actionable insight for traders with exposure to emerging market healthcare equities.

03

What to watch

FX hedge reset impact and billing penalties in Peru may affect future profitability.

Relevance 7/10Novelty 7/10Timing: Q2 earnings release

Background

Auna (NYSE:AUNA) is a Peruvian integrated healthcare services company operating across several Latin American markets.

Company-level read

Ticker impact

$AUNANeutralMedium confidence
Context

Q2 earnings released with revenue growth in Mexico, Peru, and Colombia, adjusted EBITDA trends, cash flow improvement and reaffirmed full-year guidance.

Expected impact

Potential modest upside if investors focus on cash generation and guidance reaffirmation; downside risk if EBITDA concerns dominate.

Evidence & confidence

Strong cash flow and leverage improvement offset EBITDA weakness; reaffirmed guidance suggests stability.

Market effects

Highlights growth trends in Latin American healthcare services, may influence sector peers.

Positive for Peru, Mexico, and Colombia healthcare markets.

Limited to investors with exposure to emerging market healthcare stocks.

Counterpoint

Focus on declining EBITDA margins and rising cost pressures could outweigh cash flow benefits.

Key entities

  • Auna

    Peruvian healthcare services provider listed on NYSE.

Related articles

$AUNAMed

Auna (AUNA) Q2 2026 Earnings Call Transcript

Auna (AUNA) reported Q2 2026 results with 9% revenue growth driven by volume and higher complexity services. Adjusted EBITDA declined 9% due to margin pressures in Mexico and Colombia, and billing penalties in Peru. Mexico saw 7% surgery and 20% oncology volume growth, while Peru achieved 8% revenue growth. Colombia's adjusted EBITDA increased 18% sequentially. Leverage decreased to 3.6x, and cash increased 43% year-over-year.

$AUNAMed

Auna S.A. Q2 2026 Earnings Call Summary

Auna S.A. reported Q2 2026 revenue growth of 9%, driven by high-complexity services, with adjusted EBITDA declining 9% due to investment costs. Management reaffirmed full-year revenue guidance of 12% growth and expects EBITDA growth at the low end of 10-14%. Free cash flow increased 181% due to working capital management. The company faces short-term penalties in Peru but anticipates improvements in profitability and cash flow.

$AUNAMedAI 9/10

Auna S.A.: Auna Announces 2Q26 Financial Results

Auna S.A. (NYSE: AUNA) reported 2Q26 results with revenue up 9% FX-neutral to S/1,238 million, but Adjusted EBITDA down 9% FX-neutral to S/227 million. Operating cash flow and free cash flow rose 45% and 181% YoY, respectively. The company attributed EBITDA declines to service mix and cost pressures across its Latin American markets. Auna reaffirmed its full-year revenue guidance of 12% growth and expects Adjusted EBITDA growth at the low end of its 10-14% range.

$AUNAMed

AUNA S.A. (AUNA): Financial results for Q2 2026

AUNA S.A. (AUNA) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Auna Announces 2Q26 Financial Results A consecutive quarter of strong top-line growth and cash flow performance; Consolidated Adjusted EBITDA impacted by service mix across the segments Luxembourg, August 18, 2026 – Auna (NYSE: AUNA) (“Auna” or the “Company”) , a lea

$NKEHighAI 9/10

Nike (NKE) shares fell 8.7% in after-hours trading after reporting weaker-than-expected Q1 results and announcing restructuring plans

Nike (NKE) shares fell 8.7% in after-hours trading after reporting weaker-than-expected Q1 results and announcing restructuring plans. Revenue declined 4% to $11.21B, missing estimates, while net income dropped 2% to $712M. The company forecasted a high-single-digit percentage decline in full-year revenue for fiscal 2027, steeper than market projections. China's market revenue plunged 26%, marking nine consecutive quarters of decline.